Mehta-Shah N, Lunning MA, Moskowitz AJ, Boruchov AM, et al. Romidepsin and lenalidomide based regimens have efficacy in relapsed/refractory lymphoma: combined analysis of two phase I studies with expansion cohorts. Am J Hematol 2021 Jul 12. doi: 10.1002/ajh.26288.
PMID: 34251048